In Africa, researchers are trying to answer a crucial question that has gotten relatively little attention: Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?
Outbreaks and Epidemics
Most domestic abuse hinges on isolating someone, emotionally and physically, from the outside world. That makes the pandemic ideal for abusers.
Rohit Jain captures the struggle and spirit of the children whose families were exposed to the disaster on December 2, 1984, and its after-effects.
China, which has been expanding its presence in the Western Hemisphere, is likely to beat the United States in its own backyard with vaccine diplomacy as Washington looks “at taking care of the U.S. first.”
An Indian man is suing one of the world’s largest vaccine manufacturers after falling seriously ill during a trial of a COVID-19 vaccine developed by the University of Oxford and AstraZeneca.
The investigation by the Centinela COVID-19 journalistic alliance in Brazil, Colombia, Ecuador, Guatemala, Mexico, and Nicaragua shows the many faces of this silent tragedy and the failures in official protections.
The Advisory Committee on Immunization Practices voted Tuesday that the first phase of vaccination, known as 1a, should begin with about 21 million health care workers and about 3 million adults who live in long-term care facilities.
Only 11 people who received two doses of Moderna's vaccine developed COVID-19 symptoms after being infected with the pandemic coronavirus, versus 185 symptomatic cases in a placebo group.
This story explains the TR-10 molecule and the arduous process of guaranteeing its safety and efficacy.
During the pandemic, schools in Europe and the U.S. have erected tents in their yards or expanded school gardens. Forest preschools go a step beyond that. Their advocates say nature should be the tool for learning, not just the backdrop.
The nation now has five vaccine candidates in various stages of human testing. But the design, conduct, and regulation of these trials is often opaque, said researchers, bioethicists, journalists, lawyers, and others.
In Lake Charles, Louisiana, people twice had to weigh the perils of trying to ride out an oncoming hurricane against the risk of contracting COVID-19 if they evacuated to a shelter.
Young women are at particularly high risk for HIV in parts of sub-Saharan Africa, where about 5,000 of them acquire the disease each week. Is a drug to prevent HIV really the best solution? Amy Maxmen looks at alternative solutions in South Africa.
More than half of all HIV-positive individuals will experience an eye complication during their lifetime. One such complication is CMV retinitis, which can lead to permanent blindness.
We might soon have a treatment for Huntington's disease, but the Latin American communities who helped scientists uncover the cause are too poor to benefit. Who will help these forgotten people?
Ebola survivors could be carrying live Ebola virus in their eyes. Many of them are going blind, but in fear of the epidemic's resurgence, hardly anyone is doing anything about it.
Cuban sanitariums are the government quarantine facilities for HIV positive people—critics called them prisons; supporters say they controlled the epidemic. Former residents say "it's complicated."
As plans are being made to turn Sri Lanka’s oldest leprosy hospital into a museum or a geriatric home, the few remaining patients are a living history of the stigma of the disease.
As Liberia grapples to care for thousands of Ebola survivors, scientists strive to understand post-Ebola syndrome.
An on-the-ground look at efforts in Africa and the United States to end the HIV/AIDS epidemic.
Can an emergency plan to wipe out all malaria parasites in the Mekong work before multiple drug resistance spreads? No one knows.
In rural Uganda, lack of access to healthcare results in disability and death. What can be done?
What happens when we're told to "walk a mile in his shoes" but the child has no shoes? In Ghana this is an everyday reality making harmful diseases more prevalent.
A documentary by Carl Gierstorfer follows one community’s fight for survival against Ebola through the eyes of the Liberians on the front lines battling to bring the outbreak to an end.
This week: the rise of zoonotic diseases, what really happened in the U.S. raid on Yemen, and Afghan's rule of law.
Multimedia journalist Carl Gierstorfer won Germany's Grimme award for his documentary, "We Want You to Live."
We Want You to Live - Liberia’s Fight Against Ebola is a documentary by Pulitzer Center grantee Carl Gierstorfer.
Pulitzer Center journalists Misha Friedman, Jon Cohen and Amy Maxmen spoke to 425 people about their work featured in the e-book "To End AIDS" at different events in the San Francisco area last week.
The Mercury News reported on a recent Pulitzer Center education team visit to Palo Alto High School.
Journalist Amy Maxmen receives prestigious science-writing prizes for reporting on Ebola and other diseases
Dara Mohammadi recognized for his reporting on Huntington's Disease and a new gene therapy that many sufferers may not be able to afford.
For the first time in six years, the UN has acknowledged responsibility for a cholera outbreak in Haiti that has killed thousands.
From discussing the role of journalism in ending the epidemic to focusing on women and HIV, Pulitzer Center-supported journalists present their reporting in panels, workshops and exhibitions.
"Signs of Identity" is recognized for Zalcman's "creative approach" to documenting the lives of those who survived Canada's Indian Residential Schools.
Recognition latest in awards for documentary examining homophobia in Jamaica.
The Pulitzer Center has partnered with university and college professors and teachers to design example lesson plans on journalism and public health.